Shore, N. D., De Giorgi, U., Gleave, M., Kalac, M., Tang, Y., Croitoru, R., . . . Freedland, S. J. (2026 Supplement 7). Are long-term remissions possible with hormonal therapy only? Post hoc analysis of EMBARK examining sustained prostate-specific antigen (PSA) <0.2 ng/mL despite testosterone (T) recovery after treatment (tx) suspension. Journal of Clinical Oncology, 44, 189-474.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Shore, Neal D., et al. "Are Long-term Remissions Possible with Hormonal Therapy Only? Post Hoc Analysis of EMBARK Examining Sustained Prostate-specific Antigen (PSA) <0.2 Ng/mL Despite Testosterone (T) Recovery After Treatment (tx) Suspension."
Journal of Clinical Oncology 44 (2026 Supplement 7): 189-474.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Shore, Neal D., et al. "Are Long-term Remissions Possible with Hormonal Therapy Only? Post Hoc Analysis of EMBARK Examining Sustained Prostate-specific Antigen (PSA) <0.2 Ng/mL Despite Testosterone (T) Recovery After Treatment (tx) Suspension."
Journal of Clinical Oncology, vol. 44, 2026 Supplement 7, pp. 189-474.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.